ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

“Optimal Criteria,” For Hospitals Treating Cancer Patients Developed; NCI Won’t Try Forcing Changes

November 1, 1974

Survivors Urge Congress To Include Oral Drug Coverage In Medicare Legislation

October 11, 2002

Comprehensive Centers Should Emphasize New Treatment, Group Says

July 27, 1979

Gulf Health Study Begun With $10 Million Each from NIH, BP

September 24, 2010

In Brief: Jordan To Join MD Anderson Cancer Center

July 25, 2014

FASEB urges 10 percent increase for NIH in FY 2005.

January 23, 2004